Dr. Daniel Nader is now retired from Cancer Treatment Centers of America, Tulsa. Mesothelioma patients can seek specialized treatment from other doctors in Oklahoma or nearby states.
01. Doctor Overview
Doctor Overview
Dr. Daniel Nader was a known leader in the treatment of pulmonary diseases in the Oklahoma. As Oklahoma’s representative to the American College of Chest Physicians, he served in a critical role that involved sharing his vast knowledge of pulmonary diseases. He also served as a patient advocate and lobbied for assistance from government officials. Dr. Nader’s efforts were rewarded with a seat on the board of directors of the American Association for Bronchology. Dr. Nader is now retired.
For more than two decades, Dr. Nader helped patients and developed innovative treatments for lung and chest diseases at the Cancer Treatment Centers of America, the only hospital in Oklahoma dedicated exclusively to cancer treatment. Dr. Nader had been part of CTCA since 1992, two years after the facility opened its doors. His areas of expertise included lung cancer, mesothelioma and tumors of the bronchus.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Pulmonology
Other Interests & Specialties: Pulmonology, general pulmonary medicine, interventional pulmonology, thoracic oncology, tuberculosis, chronic obstructive pulmonary disease (COPD), asthma, emphysema and pneumonia.
Certifications, Awards & Accolades: American Board of Pulmonary Disease Certification, American Board of Internal Medicine Certification, America’s Top Doctors, America’s Top Doctors for Cancer, Oklahoma Magazine Top Doctors
Education & Experience:
- Medical Degree from Kansas City University College of Osteopathic Medicine
- Residency for Internal Medicine at Naval Medical Center
- Fellowship for Pulmonary Disease at Naval Medical Center
03. Publications
Publications
Endobronchial valve treatment for prolonged air leaks of the lung: a case series. The Annals of Thoracic Surgery. January 2011;91(1):270-273. doi: 10.1016/j.athoracsur.2010.07.093
Bronchial Valve Treatment of Emphysena: Results and Conclusions from a Double-Blind Randomization Trial in Surgical and Bronchoscopic Lung Volume Reduction: State of the Art Mini Symposium. Journal of Thoracic Disease. April 2018;10(4). doi: 10.21037/jtd.2018.02.72
